Mirk Regulates the Exit of Colon Cancer Cells from Quiescence

This publication has 45 references indexed in Scilit:

• Mirk/Dyrk1B Maintains the Viability of Quiescent Pancreatic Cancer Cells by Reducing Levels of Reactive Oxygen Species
  Cancer Research, 2009
• Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase
  Nature Cell Biology, 2009
• Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
  Nature, 2009
• G0 Function of BCL2 and BCL-xL Requires BAX, BAK, and p27 Phosphorylation by Mirk, Revealing a Novel Role of BAX and BAK in Quiescence Regulation
  Journal of Biological Chemistry, 2008
• TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species
  The Journal of Experimental Medicine, 2008
• ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo
  Proceedings of the National Academy of Sciences, 2008
• p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA Damage
  Cancer Cell, 2007
• Jack-of-All-Trades “Supergene” Controls Butterfly Wing Pattern Diversity
  PLoS Biology, 2006
• A New Description of Cellular Quiescence
  PLoS Biology, 2006
• Mirk/dyrk1B Is a Rho-induced Kinase Active in Skeletal Muscle Differentiation
  Journal of Biological Chemistry, 2003